April 19, 2018 10:02 AM ET

Pharmaceuticals

Company Overview of Sandoz Inc.

Company Overview

Sandoz Inc. develops, manufactures, markets, and distributes generic pharmaceutical products. Its therapeutic drug categories include anti-infectives, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agents, oncology therapies, respiratory therapies, alimentary tract and metabolism, blood and blood-forming organs, and antineoplastic and immunomodulating agents. The company provides oral solid generics to advanced application forms, such as transdermal patches and implants; and complex products, such as follow-on biologics (biosimilars), injectables, and inhalables. It sells its products to small and large retailers, wholesalers, hospitals, prescription b...

100 College Road West

Princeton, NJ 08540

United States

Founded in 1946

Phone:

609-627-8500

Fax:

609-627-8659

Key Executives for Sandoz Inc.

President and Head of North America
Age: 53
President of Oriel Therapeutics
Vice President of Legal, IP & Compliance and General Counsel of NA
Head of Global Development Biopharmaceuticals & Oncology Injectables
Age: 64
Head of Biopharmaceuticals and Oncology Injectables
Compensation as of Fiscal Year 2017.

Sandoz Inc. Key Developments

Novartis Mulls Selling Sandoz

Novartis AG (SWX:NOVN) is considering the sale of Sandoz Laboratories, Inc.

Sandoz Wins $5,931,450 Federal Contract

Sandoz won a $5,931,450 federal contract from the Defense Logistics Agency for ethinyl estradiol and norgestimate tablets.

Sandoz Inc. Wins $9,257,190.40 Federal Contract

Sandoz Inc. won a $9,257,190.40 federal contract from the U.S. Department of Veterans Affairs for amoxicillin tablets and clavulanate potassium suspension for the VA, Department of Defense, Bureau of Prisons and Indian Health Service.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 26, 2018
ANDA Portfolio of Sandoz Inc.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sandoz Inc., please visit www.us.sandoz.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.